Labcorp to offer first FDA-cleared blood test for Alzheimer’s pathology
Labcorp says it will offer the first FDA-cleared blood test to detect Alzheimer’s disease pathology in both primary and specialty care settings.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Labcorp says it will offer the first FDA-cleared blood test to detect Alzheimer’s disease pathology in both primary and specialty care settings.